000 | 01958 a2200565 4500 | ||
---|---|---|---|
005 | 20250517095842.0 | ||
264 | 0 | _c20180718 | |
008 | 201807s 0 0 eng d | ||
022 | _a1477-0962 | ||
024 | 7 |
_a10.1177/0961203316651738 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFeng, X | |
245 | 0 | 0 |
_aArtesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus. _h[electronic resource] |
260 |
_bLupus _cJan 2017 |
||
300 |
_a62-72 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntimalarials _xadministration & dosage |
650 | 0 | 4 |
_aArtemisinins _xadministration & dosage |
650 | 0 | 4 | _aArtesunate |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 | _aHuman Umbilical Vein Endothelial Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon Type I _xmetabolism |
650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
650 | 0 | 4 |
_aIntramolecular Oxidoreductases _xdrug effects |
650 | 0 | 4 |
_aLeukocytes, Mononuclear _xdrug effects |
650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xdrug therapy |
650 | 0 | 4 |
_aMacrophage Migration-Inhibitory Factors _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 | _aReal-Time Polymerase Chain Reaction |
650 | 0 | 4 |
_aSTAT1 Transcription Factor _xgenetics |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aChen, W | |
700 | 1 | _aXiao, L | |
700 | 1 | _aGu, F | |
700 | 1 | _aHuang, J | |
700 | 1 | _aTsao, B P | |
700 | 1 | _aSun, L | |
773 | 0 |
_tLupus _gvol. 26 _gno. 1 _gp. 62-72 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/0961203316651738 _zAvailable from publisher's website |
999 |
_c26063777 _d26063777 |